E-LIB Suche - Ergebnisse für: Seiwert, T.

1

PH-0053 NBTXR3 activated by SBRT combined with nivolumab or..:

Vivar, O. ; Shen, C. ; Frakes, J....
Radiotherapy and Oncology. 161 (2021) - p. S28 , 2021

Link: https://doi.org/10.1016/..

2

Immuntherapie bei Kopf-Hals-Plattenepithelkarzinomen: Absko..:

Brix, N. ; Dunn, L. ; Seiwert, T...
best practice onkologie. 16 (2021) 11 - p. 520-527 , 2021

Link: https://doi.org/10.1007/..

3

Immuntherapie bei Kopf-Hals-Plattenepithelkarzinomen: Absko..:

Brix, N. ; Dunn, L. ; Seiwert, T...
Der Internist. 61 (2020) 7 - p. 682-689 , 2020

Link: https://doi.org/10.1007/..

4

NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Acti..:

Shen, C. ; Frakes, J.M. ; Weiss, J....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e851 , 2020

Link: https://doi.org/10.1016/..

5

Oral Cancer in the Non-Smoker, Non-Drinker Population - Is ..:

Yesensky, J. ; Hasina, R. ; Wroblewski, K....
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1357 , 2018

Link: https://doi.org/10.1016/..

6

OPTIMA—A Phase 2 Trial of Induction Chemotherapy Response-S..:

Seiwert, T. ; Melotek, J.M. ; Foster, C.C....
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1309 , 2018

Link: https://doi.org/10.1016/..

7

SP-018: HNC Biomarkers - how do we translate biology into u..:

Seiwert, T.
Radiotherapy and Oncology. 122 (2017) - p. 12 , 2017

Link: https://doi.org/10.1016/..

8

2866 Antitumor activity of the Anti-PD-1 antibody pembroliz..:

Chow, L. ; Mehra, R. ; Haddad, R....
European Journal of Cancer. 51 (2015) - p. S579 , 2015

Link: https://doi.org/10.1016/..

9

Response-Adapted Volume Deescalation (RAVD) in Locally Adva..:

Melotek, J.M. ; Villaflor, V.M. ; Brisson, R.J....
International Journal of Radiation Oncology*Biology*Physics. 93 (2015) 3 - p. E335 , 2015

Link: https://doi.org/10.1016/..

10

Response-Adapted Volume De-escalation (RAVD) in Human Papil..:

Melotek, J.M. ; Villaflor, V.M. ; Brisson, R.J....
International Journal of Radiation Oncology*Biology*Physics. 93 (2015) 3 - p. S130-S131 , 2015

Link: https://doi.org/10.1016/..

11

327 Phase II Study of Cetuximab and Lenalidomide in Recurre..:

Taylor, R. ; Wong, S. ; Chan, A....
European Journal of Cancer. 48 (2012) - p. 100 , 2012

Link: https://doi.org/10.1016/..

12

198 Assessing the role of phosphoinositide 3-kinase (PI3K) ..:

Shen, W. ; Dinali, M. El ; Braegelmann, J....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 66 , 2010

Link: https://doi.org/10.1016/..

13

255 Transcriptome sequencing of upper aerodigestive tract c..:

Braegelmann, J. ; Stricker, T. ; Brown, C....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 84 , 2010

Link: https://doi.org/10.1016/..

14

Pathologic Predictors for Outcome in Recurrent and Second P..:

Solanki, A. ; Stenson, K. ; Haraf, D....
International Journal of Radiation Oncology*Biology*Physics. 72 (2008) 1 - p. S402-S403 , 2008

Link: https://doi.org/10.1016/..

15

The Receptor Tyrosine Kinase c-MET as a Novel Therapeutic T..:

Seiwert, T. ; Janamanchi, V. ; Klein-Szanto, A....
International Journal of Radiation Oncology*Biology*Physics. 69 (2007) 2 - p. S137 , 2007

Link: https://doi.org/10.1016/..